Progress, Potential, and Possibilities Podcast / Show · 2026-07-16 · 45 min
Send us Fan Mail For decades, the war on cancer has focused on destroying cancer cells directly - with chemotherapy, radiation, and targeted drugs. But what if the future of cancer treatment is not about attacking cancer ourselves...but teaching our own immune system to do it for us? Today we're exploring a new generation of immunotherapies designed to turn the body's own defenses into a precision weapon against cancer. Over the past decade, immunotherapies such as checkpoint inhibitors and CAR-T cell therapies have transformed the treatment landscape for many cancers. But major challenges remain - including limited response rates, treatment resistance, toxicity, and the enormous complexity and cost of manufacturing many next-generation therapies. Our guest today believes the next breakthrough may come from a new generation of personalized immunotherapies designed to activate a patient’s own immune system against their cancer - while also being manufactured as an accessible, off-the-shelf treatment. Joining us is Dr. William Williams, MD - President and CEO of BriaCell Therapeutics ( ). Dr.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
How Targeted Radiotherapy Is Changing Cancer Care w/ John Babich, President, CSO, Ratio TherapeuticsCareTalk: Healthcare. Unfiltered. · on Oncology94 / 100
US Pharma Deals Midyear Outlook 2026: Why Dealmakers Are Leaning Into GrowthPwC's Next in Health · on Oncology76 / 100
Putting the “Tech” in Biotech: An Unconventional Path to Building a Therapeutics Company, with Federico Paoletti, PhDBuilding Biotechs · on Immunotherapy72 / 100
#139 Justin Coombs, COO at AusHealth on Revolutionising Healthcare Through InnovationCreating Synergy Podcast · on Immunotherapy71 / 100
This Just In Radio: CancerX 2026 with Dr. John Cleveland and Xavier AvatThis Just In Radio Show · on Immunotherapy68 / 100
Inside the Physician Decisions That Make Oncology Trials Safer & SmarterLife Science Success · on Immunotherapy54 / 100Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 10055 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton